Tag: Discontinue
Byetta Lawsuit News: Bernstein Liebhard LLP Notes British Columbia’s Recent Decision to Discontinue Incretin Mimetic Drug Coverage from PharmaCare Program
New York, NY (PRWEB) August 15, 2014 Healthcare regulators in British Columbia have stopped patient coverage of a diabetes drug now involved in hundreds of Byetta lawsuits (http://www.byettalawsuit.com/) as well as several other medications, Bernstein Liebhard LLP reports. According to a notice posted earlier this month on Merck Canada’s website, the British Columbia Medical […]